» Authors » Ali Hossein Rezayan

Ali Hossein Rezayan

Explore the profile of Ali Hossein Rezayan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 322
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Alvandi H, Asadi F, Rezayan A, Hajghassem H, Rahimi F
Anal Chim Acta . 2025 Mar; 1348:343816. PMID: 40057313
Background: Sepsis is known as one of the deadliest and costliest diseases in the world, which can be caused by bacteria or toxins and affects more than 30 million people...
2.
Alvandi H, Rezayan A, Hajghassem H, Rahimi F, Askari Moghadam R, Firoozbakhtian A
Anal Biochem . 2025 Feb; 700:115796. PMID: 39921140
Water and food-borne diseases are public health problems. It is estimated that only water-borne diseases cause 2.2 million deaths annually. E. coli is one of the most important bacteria in...
3.
Pournemati B, Tabesh H, Aghdam R, Rezayan A, Poorkhalil A, Ahmadi Tafti S, et al.
Macromol Biosci . 2024 Dec; 25(2):e2400301. PMID: 39660406
In advancing cardiac tissue engineering (CTE), the development of injectable hydrogels mirroring myocardial properties is pivotal. The designed hydrogels must not only support cardiac cell growth but also have to...
4.
Alvandi H, Rezayan A, Hajghassem H, Rahimi F
Talanta . 2024 Nov; 283:127184. PMID: 39520924
Every year, millions of people suffer from gastrointestinal inflammation caused by E. coli. The increase of antibiotic-resistant strains and similar inflammatory and infectious syndromes symptoms have made rapid and sensitive...
5.
Akbari M, Rezayan A, Rastegar H, Alebouyeh M, Yahyaei M
Drug Dev Res . 2024 Feb; 85(1):e22148. PMID: 38349268
The emergence of antibiotic-resistant bacterial infections is a principal threat to global health. Functionalization of nanomaterial with antibiotics is known as a useful method for increasing the effectiveness of existing...
6.
Shakibay Senobari Z, Hosseini M, Teimouri M, Rezayan A, Samarghandian S, Hekmat A
BMC Res Notes . 2023 Sep; 16(1):224. PMID: 37735703
Background: COVID-19 is a respiratory illness caused by SARS-CoV-2. Pharmaceutical companies aim to control virus spread through effective drugs. This study investigates chromone compound derivatives' ability to inhibit viral entry...
7.
Hamedinasab H, Rezayan A, Jaafari M, Mashreghi M, Alvandi H
J Microencapsul . 2023 May; 40(5):357-365. PMID: 37147916
Aim: N-acetylcysteine (NAC) is an antioxidant used to moderate liposome and chitosan-induced cell cytotoxicity at their high concentrations. Methods: Liposome and chitosan were prepared and characterised. The cytotoxicity effect of...
8.
Hosseini S, Mohammadnejad J, Yousefnia H, Alirezapour B, Rezayan A
J Cancer Res Clin Oncol . 2023 Apr; 149(10):7779-7791. PMID: 37029816
Purpose: Epidermal growth factor receptors (EGFRs) are overexpressed in a wide range of tumors and are attractive candidates to target in targeted therapies. This study aimed to introduce a novel...
9.
Vahedi S, Aghdam R, Heydarzadeh Sohi M, Rezayan A
J Mater Sci Mater Med . 2023 Jan; 34(1):8. PMID: 36630012
Mg-based biomaterials are commonly used as biodegradable orthopedic implants (e.g., bone regeneration applications). However, achieving high biocompatibility and corrosion resistance has remained a challenge to be tackled. In this work,...
10.
Hosseinniay S, Rezayan A, Ghasemi F, Malekmohamadi M, Taheri R, Hosseini M, et al.
Anal Chim Acta . 2022 Nov; 1237:340580. PMID: 36442946
C-reactive protein (CRP) is a plasma protein that is one of the most expressed proteins in acute phase inflammation cases. It is a well-known biomarker for inflammatory disorders. There is...